Early detection and aggressive treatment of prostate cancer: groping in the dark.

about

Prostate-specific antigen in the early detection of prostate cancer.Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients?

P2860

Q35840271-DB8BB3C7-BB72-4F38-8CC7-1180589E76C4 Q51019734-FB90F839-7EF7-4D03-89E0-4287939B34FC

P2860

Early detection and aggressive treatment of prostate cancer: groping in the dark.

Item

http://www.wikidata.org/entity/Q42345809

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@en

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@nl

type

Item

label

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@en

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@nl

prefLabel

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@en

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@nl

P1476

Early detection and aggressive treatment of prostate cancer: groping in the dark.

@en

P2093

M J Barry

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-re ported complications and follow-up treatment after radical prostatectomy

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.

Prostate cancer detection at low prostate specific antigen.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

A decision analysis for treatment of clinically localized prostate cancer.

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Population-based study of long-term survival in patients with clinically localised prostate cancer.

P2888

j.1525-1497.2000.00816.x

P304

749-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1046/J.1525-1497.2000.00816.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229813970

http://www.w3.org/2001/XMLSchema#string

P6179

1006123486

http://www.w3.org/2001/XMLSchema#string

P698

11089719

http://www.w3.org/2001/XMLSchema#string

P932

1495598

http://www.w3.org/2001/XMLSchema#string

Early detection and aggressive treatment of prostate cancer: groping in the dark.

about

P2860

P2860

Early detection and aggressive treatment of prostate cancer: groping in the dark.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932